| scholarly article | Q13442814 |
| P50 | author | Jessica Zucman-Rossi | Q43376269 |
| Jean Charles Nault | Q58392544 | ||
| P2093 | author name string | Jean Charles Nault | |
| Jessica Zucman Rossi | |||
| P2860 | cites work | Control of pancreas and liver gene expression by HNF transcription factors | Q24618003 |
| Wnt/β-catenin signaling and disease | Q26823272 | ||
| Immunity, Inflammation, and Cancer | Q27861048 | ||
| Bi-allelic inactivation of TCF1 in hepatic adenomas | Q28204646 | ||
| Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease | Q28209487 | ||
| Epidemiology of hepatocellular adenoma. The role of oral contraceptive use | Q28255430 | ||
| Genotype phenotype classification of hepatocellular adenoma | Q28306241 | ||
| Apc tumor suppressor gene is the "zonation-keeper" of mouse liver | Q28589915 | ||
| Liver-targeted disruption of Apc in mice activates beta-catenin signaling and leads to hepatocellular carcinomas | Q28592004 | ||
| Beta-catenin is temporally regulated during normal liver development | Q28594237 | ||
| Liver adenomatosis: reappraisal, diagnosis, and surgical management: eight new cases and review of the literature | Q33818077 | ||
| Synchronous hepatocellular carcinoma and Castleman's disease: the role of the interleukin-6-signaling pathway | Q84178534 | ||
| Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience | Q84194027 | ||
| Spectrum of HNF1A somatic mutations in hepatocellular adenoma differs from that in patients with MODY3 and suggests genotoxic damage | Q33930343 | ||
| HNF1α inhibition triggers epithelial-mesenchymal transition in human liver cancer cell lines | Q34040991 | ||
| Activating mutations of the stimulatory G protein in the McCune-Albright syndrome | Q34981177 | ||
| Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas | Q35102345 | ||
| Minireview: GNAS: normal and abnormal functions. | Q35872586 | ||
| Overview of hepatocellular adenoma in Japan | Q36224975 | ||
| Telangiectatic adenoma: an entity associated with increased body mass index and inflammation. | Q36863160 | ||
| Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma | Q36998804 | ||
| Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours | Q37224637 | ||
| Revisiting the pathology of resected benign hepatocellular nodules using new immunohistochemical markers | Q37846152 | ||
| Genetics of hepatobiliary carcinogenesis | Q37871482 | ||
| The value of immunophenotyping hepatocellular adenomas: consecutive resections at one UK centre. | Q38047335 | ||
| Liver adenomatosis. An entity distinct from liver adenoma? | Q38152939 | ||
| HNF1alpha inactivation promotes lipogenesis in human hepatocellular adenoma independently of SREBP-1 and carbohydrate-response element-binding protein (ChREBP) activation | Q38303475 | ||
| Loss of hepatocyte nuclear factor 1alpha function in human hepatocellular adenomas leads to aberrant activation of signaling pathways involved in tumorigenesis | Q39757776 | ||
| Liver-Cell Adenomas Associated with Use of Oral Contraceptives | Q39969798 | ||
| A clinicopathologic study of steroid-related liver tumors | Q40127273 | ||
| The Association Between Oral Contraception and Hepatocellular Adenoma - A Preliminary Report | Q40128935 | ||
| Hepatocellular adenomas in glycogen storage disease type I and III: a series of 43 patients and review of the literature | Q41460619 | ||
| Constitutively active mutant gp130 receptor protein from inflammatory hepatocellular adenoma is inhibited by an anti-gp130 antibody that specifically neutralizes interleukin 11 signaling | Q42141408 | ||
| Double heterozygous germline HNF1A mutations in a patient with liver adenomatosis | Q42539641 | ||
| Inflammatory syndrome with liver adenomatosis: the beneficial effects of surgical management. | Q42843389 | ||
| Utility of an immunohistochemical panel consisting of glypican-3, heat-shock protein-70, and glutamine synthetase in the distinction of low-grade hepatocellular carcinoma from hepatocellular adenoma. | Q43858642 | ||
| Hepatocellular adenomas: accuracy of magnetic resonance imaging and liver biopsy in subtype classification | Q45269686 | ||
| Telangiectatic focal nodular hyperplasia: a variant of hepatocellular adenoma. | Q47635380 | ||
| Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3) | Q48056898 | ||
| Immunohistochemical markers on needle biopsies are helpful for the diagnosis of focal nodular hyperplasia and hepatocellular adenoma subtypes. | Q51310816 | ||
| Management of spontaneous haemorrhage and rupture of hepatocellular adenomas. A single centre experience. | Q51809314 | ||
| Modern oral contraceptive use and benign liver tumors: the German Benign Liver Tumor Case-Control Study. | Q52980364 | ||
| P53 gene and Wnt signaling in benign neoplasms: beta-catenin mutations in hepatic adenoma but not in focal nodular hyperplasia. | Q54537634 | ||
| Chromosomal and genetic alterations in human hepatocellular adenomas associated with type Ia glycogen storage disease. | Q54720176 | ||
| Changing trends in malignant transformation of hepatocellular adenoma | Q57782508 | ||
| A Single-Center Surgical Experience of 122 Patients With Single and Multiple Hepatocellular Adenomas | Q57782528 | ||
| Genotype–phenotype correlation in hepatocellular adenoma: New classification and relationship with HCC | Q57782566 | ||
| Diagnostic value of HSP70, glypican 3, and glutamine synthetase in hepatocellular nodules in cirrhosis | Q57972703 | ||
| Hepatocellular carcinoma occurring in nonfibrotic liver: Epidemiologic and histopathologic analysis of 80 French cases | Q57981006 | ||
| Association of CYP1B1 Germ Line Mutations with Hepatocyte Nuclear Factor 1 -Mutated Hepatocellular Adenoma | Q58408284 | ||
| Clinical, Morphologic, and Molecular Features Defining So-Called Telangiectatic Focal Nodular Hyperplasias of the Liver | Q58408401 | ||
| Chromosomal analysis of hepatic adenoma and focal nodular hyperplasia by comparative genomic hybridization | Q58814564 | ||
| p53 gene and Wnt signaling in benign neoplasms: β-catenin mutations in hepatic adenoma but not in focal nodular hyperplasia | Q58814584 | ||
| Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry | Q59938985 | ||
| Validation of a liver adenoma classification system in a tertiary referral centre: Implications for clinical practice | Q62528368 | ||
| GNAS-activating mutations define a rare subgroup of inflammatory liver tumors characterized by STAT3 activation | Q64041199 | ||
| Management of focal nodular hyperplasia and hepatocellular adenoma in young women: a series of 41 patients with clinical, radiological, and pathological correlations | Q71564994 | ||
| Regression of liver cell adenoma. A follow-up study of three consecutive patients after discontinuation of oral contraceptive use | Q72923169 | ||
| Familial liver adenomatosis associated with hepatocyte nuclear factor 1alpha inactivation | Q79249658 | ||
| Regressive liver adenomatosis following androgenic progestin therapy withdrawal: a case report with a 10-year follow-up and a molecular analysis | Q80400140 | ||
| Nuclear beta-catenin staining and absence of steatosis are indicators of hepatocellular adenomas with an increased risk of malignancy | Q81369291 | ||
| Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification | Q81758885 | ||
| Targeted deletion of liver glucose-6 phosphatase mimics glycogen storage disease type 1a including development of multiple adenomas | Q82615010 | ||
| Liver cell adenoma: a multicenter analysis of risk factors for rupture and malignancy | Q83159185 | ||
| Hepatocellular adenoma subtypes: the impact of overweight and obesity | Q83690357 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 315947 | |
| P577 | publication date | 2013-01-15 | |
| P1433 | published in | International Journal of Hepatology | Q26853849 |
| P1476 | title | Molecular classification of hepatocellular adenomas | |
| P478 | volume | 2013 |
| Q26864205 | Current concepts in the immunohistochemical evaluation of liver tumors |
| Q58585288 | Cystic degeneration of hepatic adenoma: a rare complication of hepatic adenoma |
| Q37578014 | Expression of liver fatty acid binding protein in hepatocellular carcinoma. |
| Q39262323 | Functional genomics identified a novel protein tyrosine phosphatase receptor type F-mediated growth inhibition in hepatocarcinogenesis |
| Q57301412 | Molecular classification of hepatocellular adenomas: impact on clinical practice |
| Q36096703 | Treatment of Hepatic Adenomatosis |
| Q53211834 | [Hepatocellular tumours in noncirrhotic liver tissue]. |
Search more.